医学部スポーツ医学総合センター

Yataba, I., Kamada, Y., Matsushita, I., Matsumoto, H., Hoshino, Y. & Sato, A., 2019 1 1, ： : Japanese Pharmacology and Therapeutics. 47, 3, p. 395-404 10 p.

研究成果: Article

Flurbiprofen

Osteoarthritis

Anti-Inflammatory Agents

Safety

Pharmaceutical Preparations

3 引用 (Scopus)

Spinal epidural lipomatosis is a previously unrecognized manifestation of metabolic syndrome

Ishihara, S., Fujita, N., Azuma, K., Michikawa, T., Yagi, M., Tsuji, T., Takayama, M., Matsumoto, H., Nakamura, M., Matsumoto, M. & Watanabe, K., 2019 3 1, ： : Spine Journal. 19, 3, p. 493-500 8 p.

研究成果: Article

Lipomatosis

Fats

Intra-Abdominal Fat

Subcutaneous Fat

Odds Ratio

1 引用 (Scopus)

Accuracy of basal metabolic rate estimated by predictive equations in Japanese with type 2 diabetes

Tabata, S., Kinoshita, N., Yamada, S. & Matsumoto, H., 2018 7 1, ： : Asia Pacific Journal of Clinical Nutrition. 27, 4, p. 763-769 7 p.

研究成果: Article

Basal Metabolism

Type 2 Diabetes Mellitus

Weights and Measures

Bone Density

Fasting

医学部スポーツ医学総合センター

佐藤 和毅

田畑 尚吾

Cardiovascular Safety of Long-term Topical Application of a New Non-steroidal Anti-inflammatory Drug, S-flurbiprofen, in Patients with Osteoarthritis

Spinal epidural lipomatosis is a previously unrecognized manifestation of metabolic syndrome

Accuracy of basal metabolic rate estimated by predictive equations in Japanese with type 2 diabetes

佐藤和毅

田畑尚吾